Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 29;18:8113–8130. doi: 10.2147/IJN.S434579

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Liang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Anti-inflammatory effect of AgNPs and ebselen on P. gingivalis-infected HGFs. (A) The schematic diagram for the application of AgNPs and ebselen in P. gingivalis-infected HGFs, created with BioRender.com; (B) Relative mRNA and (C) protein expression levels of IL-6, IL-8, and CCL2 in P. gingivalis-infected HGFs; (D) Relative expression of SOD2 mRNA in P. gingivalis-infected HGFs; (E) Autophagic flux in P. gingivalis-infected HGFs with the treatment of AgNPs and ebselen (scale bars: 5 μm). Data were presented as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001.